| |
|
|
|
Millendo Therapeutics Inc.  
|
|
7.92 0.19 (0.02%) |
11-15 16:00 |
|
Open: |
7.81 |
Pre close: |
7.73 |
Target:
|
9.76
|
|
High: |
8 |
Low: |
7.72 |
Resistance:
|
8.36
9.76
|
|
Volume: |
12,287 |
Market Cap: |
107M |
Support:
|
7.29
6.64
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.75
 |
MACD |
MACD(12,26):
|
0.20 |
|
MA(20): |
7.59 |
Signal(12,26,9): |
0.21  |
|
MA(100): |
8.02 |
Stochastic Oscillator |
%K(14,3):
|
52.85 |
|
MA(250): |
10.77 |
%D(3): |
51.49 |
|
Average Volume(K) |
3-Month: |
3172
|
52-Week |
High:
|
17.34 |
|
10-Days: |
1543 |
Low: |
4.56 |
|
RSI |
RSI(14):
|
58.71 |
Change(%): |
-22.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.860 |
Return on Equity (ttm) |
-124.3 |
Shares Out. (M) |
13.41 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-54.8 |
Shares Float (M) |
5.68 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.03 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
59.14 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
232 |
|
Book Value (p.s.) |
3.950 |
EBITDA (p.s.) |
-2.571 |
P/E |
-1.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.01 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-35.12 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-18.77 |
P/CF |
-3.02 |
|
|
|
|
|
|
